Deoxy Ltd Company Profile

13:32 EST 12th December 2018 | BioPortfolio

DEOXY is an emerging glycotechnology company, dedicated to providing carbohydrates that contribute to improvement of health and quality of life. Privately held, our ambition is to establish the company's position in the area of glycotechnology,focussing on nutraceuticals and biomedicine. Our efforts are presently directed at new products for the treatment of gastrointestinal disorders. The commercialisation of innovative bifidogenic prebiotics, resulting from this initiative, has been our central priority; centred around fourprimaryhealth propositions, namely improving general gut health, lowering blood cholesterol, improving the body's natural defences and mineral absorption.


The Mill Business CentreCrosses Green Cork


Phone: 353 21 4291 260
Fax: 353 21 4291 260

Drugs and Medications [32 Associated Drugs and Medications listed on BioPortfolio]

Heparin sodium in dextrose [B. Braun Medical Inc.]

Heparin Sodium in 5% Dextrose Injection

Cladribine [Bedford Laboratories]


Cladribine [Bedford Laboratories]


Cladribine [Onco Therapies Limited ]

Cladribine Injection

Gentamicin sulfate [Falcon Pharmaceuticals, Ltd.]

Gentamicin Sulfate Ophthalmic Solution USP

PubMed Articles [79 Associated PubMed Articles listed on BioPortfolio]

Synthesis of novel 3'-azido-3'-deoxy-α-L-ribo configured nucleosides: A comparative study between chemical and chemo-enzymatic methodologies.

Syntheses of novel 3'-azido-3'-deoxy-2'-O,4'-C-methylene-α-L-ribofuranosyl nucleosides have been carried out from 3'-azido-3'-deoxy-4'-C-hydroxymethyl-β-D-xylofuranosyl nucleosides following both ch...

Trainability of hemodynamic parameters: A near-infrared spectroscopy based neurofeedback study.

We investigated the trainability of the hemodynamic response as assessed with near-infrared spectroscopy (NIRS) during one neurofeedback (NF) session. Forty-eight participants were randomly assigned t...

Stereoselective synthesis of 2-deoxy-β-C-aryl/alkyl glycosides using Prins cyclization: Application in the synthesis of C-disaccharides and differently protected C-aryl glycosides.

2-Deoxy-β-C-aryl/alkyl glycosides were synthesized from di-O-pivaloyl protected homoallylic alcohol derived from D-mannitol with various aldehydes via the Prins cyclization. The salient features of t...

Synthesis and Photophysical Studies on N-(2'-O,4'-C-Methyleneribofurano-nucleoside-3'-yl)-C-(coumarin-7-oxymethyl)-1,2,3-triazoles.

A series of eight N-(2'-O,4'-C-methylene-β-D-ribofuranonucleoside-3'-yl)-C-(coumarin-7-oxymethyl)-1,2,3-triazoles have been synthesized by Cu(I)-catalyzed azide-alkyne cycloaddition reaction of 3'-az...

Improved synthesis of the Kijanimicin oligodeoxytetrasaccharide.

By sequential synthesis the four 2,6-dideoxy saccharide moieties of the kijanimicin tetrasaccharide could be stereoselectively assembled. For formation of all required 2-deoxy α-glycoside linkages va...

Clinical Trials [54 Associated Clinical Trials listed on BioPortfolio]

Dose Escalation Trial of 2-Deoxy-D-Glucose (2DG) in Subjects With Advanced Solid Tumors

The objectives of this study are to evaluate the safety, tolerability, pharmacokinetics, and biologic effect (FDG PET, preliminary efficacy) of daily oral doses of 2DG with and without wee...

3'-Deoxy-3'-[18F] Fluorothymidine and Fludeoxyglucose F 18 PET Scans in Evaluating Response to Cetuximab, Cisplatin, and Radiation Therapy in Patients With Advanced Cancer of the Oropharynx, Larynx, or Hypopharynx

RATIONALE: Diagnostic procedures, such as 3'-deoxy-3'-[18F] fluorothymidine (FLT) and fludeoxyglucose F 18 (FDG) PET scans, may help doctors predict a patient's response to treatment and h...

Safety and Efficacy Study of FLT Radiolabeled Imaging Agent With PET Scan in Invasive Breast Cancer

This trial will test the effectiveness of a new imaging agent, [F-18] FLT, in predicting the success of chemotherapy treatment. Imaging agents are drugs that are given before or during an ...

A Study of Changes in FDG- and FLT-PET Imaging in Patients With Non-Small Cell Lung Cancer Following Treatment With Erlotinib

This is a single-arm, open-label, multicenter, international pilot study to evaluate changes that occur in FDG- and FLT-PET imaging as a result of treatment with erlotinib in patients with...

A Multi-Center, Open-Label, Ascending, Multiple Oral Dose, Safety, Tolerance and Pharmacokinetic Study of 3'-Deoxy-3'-Fluorothymidine (FLT) in Patients With Acquired Immune Deficiency Syndrome (AIDS) or AIDS-Related Complex (ARC)

To assess the tolerance and toxicity profile of deoxy-3'-fluorothymidine (FLT) after multiple oral dosing for 16 weeks. To characterize the steady-state pharmacokinetics of FLT after multi...

Companies [1 Associated Companies listed on BioPortfolio]

Deoxy Ltd

DEOXY is an emerging glycotechnology company, dedicated to providing carbohydrates that contribute to improvement of health and quality of life. Privately held, our ambition is to establish the compan...

More Information about "Deoxy Ltd" on BioPortfolio

We have published hundreds of Deoxy Ltd news stories on BioPortfolio along with dozens of Deoxy Ltd Clinical Trials and PubMed Articles about Deoxy Ltd for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Deoxy Ltd Companies in our database. You can also find out about relevant Deoxy Ltd Drugs and Medications on this site too.

Quick Search


Relevant Topics

Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...

Cholesterol is a waxy steroid metabolite found in the cell membranes and transported in the blood plasma. It is an important structural component of mammalian cell membranes, where it is establishes proper membrane permeability and fluidity. Cholesterol ...

Corporate Database Quicklinks

Searches Linking to this Company Record